Redeye: Addnode Group - Impressive organic growth, again

We leave our 2020 forecast regarding both sales and EBITA unchanged. However, we lower our estimate for Q4 2019, mainly as we expect customers in PLM to choose SaaS over licenses to a larger extent, due to uncertainty over the economic outlook. Although, in the long run, we prefer SaaS over licenses. We raise our Base case insignificantly to SEK 151 (147).

Read more and download the research update: http://bit.ly/2NwfvOQ

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/